We, in our study, reconfirmed GDPD5 as the downstream target gene of miR-874-3p, and found that GDPD5 silencing not only repressed the viability but also led to a reversion on the effects of miR-874-3p downregulation on GC cells. The gene discussed is GDPD5; the disease is gastric cancer.